Article
Safety and Tolerability of Low-Dose Full-Spectrum Cannabidiol in Long-Term Virally Suppressed Adults with HIV: A Randomized Double-Blind Placebo-Controlled Trial
2026-03-24
Abstract excerpt
<h4>Introduction</h4> People with long-term virologically suppressed HIV (PWH) experience chronic inflammation. Beneficial effects such as lower levels of inflammation were reported for cannabis-based medicine but data on the safety of standardized low-dose full-spectrum cannabidiol (CBD) are limited. <h4>Methods</h4> This double-blind randomized placebo-controlled trial ( NCT05306249 ) included 80 ART-treated...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 11adcf76-7cb0-5ee4-9fc2-b2de4dae284b
- DOI
- 10.64898/2026.03.21.26348972
